Parsons to Highlight Intelligent Transportation Solutions at ITS World Congress

Parsons Corporation (NYSE: PSN) will highlight industry-leading intelligent transportation solutions (ITS) that are helping cities around the world move safer, faster, and smarter during ITS World Congress on Sept. 18-22, 2022, in Los Angeles.

The company has delivered integrated automatic traffic management systems (ATMS) for decades and is now deploying projects utilizing new artificial intelligence (AI) efforts, including basic AI, advanced AI, and machine learning (ML).

“The future of our infrastructure depends on our ability to integrate innovative, intelligent solutions that will improve efficiency, safety, and sustainability” said Robert Suess, senior vice president, intelligent infrastructure sector for Parsons. “Our infrastructure, traffic, and technology experts will be on-hand during ITS World Congress to discuss how Parsons is transforming transportation by delivering smarter, faster mobility solutions.”

During the show, Parsons will highlight the company’s traffic management capabilities, including the iNET™ Smart Mobility Platform and Intelligent Intersections Solution. The company was recently recognized by the International Road Federation (IRF) with the Global Road Achievement Award for the deployment of iNET™ on the San Francisco Oakland Bay Bridge – a project leveraging fuzzy logic AI.

Parsons’ Smart Mobility team also lent their expertise to the proceedings, participating in several panel discussions, including:

  • Dan Lukasik, vice president, Smart Mobility, and Derek Pines, vice president, ITS, both joined the panel, “California – Leading the Way in Connected Autonomous Vehicle Advancements.”
  • Emily Silverman, principal project manager, was a panelist on “Planes, Trains, and Automobiles! (plus Trucks, Boats, Pedestrians): Working to Solve Multi-Modal Connectivity Through Technology.”

To learn more about Parsons’ advanced traffic management solutions, visit:

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.